Your session is about to expire
← Back to Search
Procedure
Ureteroscopy for Kidney Stones (UPURS Trial)
N/A
Recruiting
Led By Thomas Chi, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of symptoms (pain, nausea, vomiting, hematuria)
Adult (> 18 yo)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
UPURS Trial Summary
This trial will compare two ways to treat a ureteral stone. One way is to start treatment right away, the other is to wait and see if it gets better.
Who is the study for?
The UPURS trial is for adults over 18 who come to the emergency department with symptoms like pain, nausea, vomiting, or blood in urine due to a ureteral stone that's at least 5mm big as seen on a CT scan. It's not for those with certain urinary structures, large stones unsuitable for URS, transplant kidneys, strong surgery preferences, need for stents due to other conditions, or untreated urinary infections.Check my eligibility
What is being tested?
This study compares two approaches: immediate ureteroscopy (a procedure using a scope to remove the stone) versus waiting and only performing the procedure if necessary later on. Participants are randomly assigned to one of these strategies when they show up at the hospital with kidney stone symptoms.See study design
What are the potential side effects?
Ureteroscopy can cause side effects such as discomfort or pain during and after the procedure, bleeding in urine temporarily post-operation, possible infection risk requiring antibiotics treatment and rarely injury to ureters which might need further surgical intervention.
UPURS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am experiencing symptoms like pain, nausea, or blood in urine.
Select...
I am over 18 years old.
UPURS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Anxiety Score
Pain Score
Secondary outcome measures
Hospital visit length
Other outcome measures
Days of work lost
Hospital visits
UPURS Trial Design
2Treatment groups
Active Control
Group I: Group B (Observation/delayed ureteroscopy)Active Control1 Intervention
Group II: Group A (Upfront ureteroscopy)Active Control1 Intervention
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,507 Previous Clinical Trials
15,238,475 Total Patients Enrolled
2 Trials studying Kidney Stones
3,471 Patients Enrolled for Kidney Stones
Thomas Chi, MDPrincipal InvestigatorUniversity of California, San Francisco
5 Previous Clinical Trials
400 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My kidney stones cannot be treated with a scope through the urethra.You have a kidney stone that is 5 millimeters or larger as seen on a CT scan.I prefer surgery or monitoring over other treatments.I have a transplanted kidney.I am experiencing symptoms like pain, nausea, or blood in urine.You have a specific medical need for a stent.Your urine test shows signs of infection or other problems.My health conditions are not stable enough for surgery.You have a medical device in your body.I am over 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Group B (Observation/delayed ureteroscopy)
- Group 2: Group A (Upfront ureteroscopy)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies open for prospective participants in this experiment?
"As per the information hosted on clinicaltrials.gov, this experiment is not taking applications at present. The post was initially published on March 1st 2023 and last modified on February 2nd 2023; however, there are 54 other trials actively seeking participants right now."
Answered by AI
Share this study with friends
Copy Link
Messenger